The global pressure monitoring market size was estimated at USD 11.6 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2030. The increasing prevalence of chronic diseases, such as hypertension, cardiovascular diseases, and respiratory disorders, has significantly boosted the demand for pressure monitoring devices. Hypertension alone affects over a billion people worldwide, necessitating regular monitoring to manage the condition effectively. According to a report by WHO, 1.28 billion adults aged 30-79 worldwide suffer from hypertension, with the majority residing in middle-income countries. Additionally, it is estimated that 46% of the population with hypertension are not aware of their condition.
Chronic diseases often require lifelong management, including frequent pressure monitoring to prevent complications. As the global population ages and the incidence of chronic conditions rises, the need for reliable and efficient pressure monitoring solutions becomes more critical. According to a Medscape report from April 2024, hypertension is the most prevalent primary diagnosis in the U.S. It affects about 86 million adults aged 20 and older and is a significant risk factor for stroke, vascular disease, myocardial infarction, and chronic kidney disease. This trend is anticipated to sustain the market's upward trajectory as healthcare providers and patients seek effective ways to manage chronic illnesses.
In addition, the global demographic shift towards an aging population is another key driver of the market. Older adults are more susceptible to health issues such as hypertension, heart disease, and respiratory conditions, all of which require regular pressure monitoring. As life expectancy increases, there is a corresponding rise in the number of elderly individuals who need continuous health monitoring. This demographic trend is particularly pronounced in developed regions with advanced healthcare infrastructure. The growing geriatric population not only increases the demand for pressure monitoring devices but also drives the development of more accessible and user-friendly technologies tailored to older adults.
Furthermore, innovations such as wireless connectivity, integration with digital health platforms, and miniaturization of devices have made pressure monitoring more efficient and user-friendly. These advancements have broadened the application scope, allowing for more accurate and real-time monitoring of various conditions. For instance, the development of non-invasive devices for blood pressure monitoring has revolutionized patient care by enabling continuous monitoring outside of clinical settings. As technology continues to evolve, it is expected that newer, more sophisticated pressure monitoring solutions will emerge, further driving market growth.
The pressure monitoring market is characterized by a high degree of innovation, driven by advancements in sensor technology, wireless connectivity, and integration with digital health platforms. Innovations such as non-invasive monitoring, miniaturized devices, and real-time data analytics have enhanced accuracy, convenience, and patient outcomes, significantly contributing to market growth and expanding the scope of applications.
The market has seen a robust level of mergers and acquisitions (M&A) activity, as major players seek to enhance their technological capabilities and market reach. For instance, in April 2024, OMRON Healthcare, Co., Ltd. acquired Luscii Healthtech, a player in the digital health and remote consultation service platforms industry. These strategic acquisitions aim to integrate advanced technologies, expand product portfolios, and penetrate new markets, thereby driving innovation, improving competitive positioning, and fostering overall market growth.
Regulations in the market play a crucial role in ensuring device safety, efficacy, and quality. Compliance with stringent standards set by regulatory bodies like the FDA and EMA fosters trust and reliability. However, navigating these regulatory frameworks can also pose challenges, potentially slowing down innovation and market entry for new products.
Product expansion in the market is high, driven by continuous innovation and the growing demand for advanced monitoring solutions. Companies are actively developing new devices with enhanced features, such as wireless capabilities and real-time data tracking, to meet diverse healthcare needs. For instance, in May 2021, Biobeat, a provider of wearable remote patient monitoring solutions for healthcare, announced the launch of a wearable and continuous ambulatory blood pressure monitoring chest device. This expansion helps cater to a broader patient base and supports the market's robust growth trajectory.
Regional expansion in the market is moderate, with significant growth observed in emerging markets across Asia-Pacific, Latin America, and the Middle East. Increasing healthcare investments, rising awareness of chronic diseases, and improvements in healthcare infrastructure drive this expansion, enabling broader access to advanced pressure monitoring technologies and fueling overall market growth.
The BP monitors/cardiac pressure monitors segment dominated the market in terms of revenue share of 40.8% in 2023 and is anticipated to grow at the fastest CAGR during the forecast period, driven by the increasing prevalence of cardiovascular diseases and hypertension. Technological advancements, such as wireless and wearable devices, enhance patient compliance and monitoring accuracy. For instance, in January 2024, Samsung announced the introduction of blood pressure and electrocardiogram tracking features for the Galaxy Watch6 series in India for the first time, available through an over-the-air rollout. Rising health awareness and the need for regular monitoring of chronic conditions further fuel demand. Additionally, the expansion of telehealth services and home healthcare solutions significantly contribute to the segment's growth, making these devices more accessible and convenient for patients globally.
The pulmonary pressure monitors segment is experiencing notable growth, driven by the increasing prevalence of pulmonary diseases such as pulmonary hypertension and chronic obstructive pulmonary disease (COPD). Recent product launches featuring advanced monitoring technologies enhance early diagnosis and disease management. For instance, innovative wearable devices provide continuous monitoring, improving patient outcomes. As awareness of pulmonary conditions rises and healthcare infrastructure advances, the demand for accurate and reliable pulmonary pressure monitoring solutions continues to expand, bolstering market growth.
The noninvasive segment dominated the market and accounted for a 54.6% share in 2023 and is anticipated to grow at the fastest CAGR of 9.1%. This surge is fueled by increasing patient preference for noninvasive methods due to their safety, comfort, and reduced risk of complications compared to invasive procedures. Technological advancements have led to the development of highly accurate and reliable noninvasive monitoring devices, such as wrist-worn and finger-worn blood pressure monitors. The rising prevalence of chronic diseases, coupled with growing awareness about regular health monitoring, further drives demand. Additionally, the expansion of telemedicine and home healthcare services enhances the accessibility and adoption of noninvasive pressure monitoring solutions, significantly contributing to market growth.
The invasive procedure segment is experiencing steady growth, primarily driven by its critical role in accurately monitoring patients in intensive care and surgical settings. These procedures are essential for managing severe cardiovascular conditions and complex surgeries, where precise and continuous pressure monitoring is crucial. Advances in sensor technology and catheter designs have improved the safety and efficacy of invasive monitoring. Despite the rise of noninvasive methods, the demand for invasive pressure monitors remains robust due to their unmatched accuracy and reliability in critical care situations.
The cardiac disorders segment held the largest market share of 41.8% in 2023. Factors such as the increasing prevalence of cardiovascular disorders, rising aging populations, and heightened awareness of heart health contribute to this expansion. According to the CDC, one person dies from cardiovascular disease every 33 seconds. In 2022, heart disease claimed 702,880 lives, accounting for 1 in every 5 deaths. Innovations in pressure monitoring technology, including wearable and home-based devices, facilitate early detection and management of cardiac conditions. Additionally, improved healthcare infrastructure and supportive government initiatives further bolster market growth, as effective monitoring is essential for preventing and managing cardiovascular diseases.
The respiratory disorders segment is expected to grow at the fastest CAGR over the forecast period, due to the increasing prevalence of conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. Advances in pressure monitoring technology, including portable and noninvasive devices, have improved disease management and patient outcomes. Additionally, growing awareness about the importance of regular monitoring and early detection of respiratory issues, coupled with improved healthcare infrastructure, further boosts the demand for pressure monitoring solutions in this segment.
The hospitals dominated the market with the largest revenue share of 41.1% in 2023, due to the rising prevalence of chronic diseases and the increasing need for accurate, continuous patient monitoring. Advances in medical technology and the expansion of healthcare infrastructure enhance the adoption of sophisticated pressure monitoring devices in hospitals, improving patient care and outcomes.
The home monitoring segment is expected to experience the fastest CAGR over the forecast period. This growth is driven by an increasing preference for home-based health management and the growing availability of user-friendly, accurate monitoring devices. Advances in technology have made it easier for people to track their blood pressure and other vital signs from home. This trend is further supported by rising health awareness and the convenience of remote monitoring, which helps patients manage chronic conditions effectively.
North America dominated the market and accounted for a 39.5% share in 2023, driven by the rising prevalence of hypertension and high blood pressure. Nearly half of the adults in the U.S., approximately 116 million individuals, have hypertension. Advanced monitoring technologies and increased health awareness are key trends fueling this expansion. The demand for accurate, user-friendly home monitoring devices is growing, reflecting a broader trend towards preventive healthcare. Additionally, the integration of digital health solutions and telemedicine is enhancing patient management and compliance, further boosting the market. These factors collectively contribute to the robust growth of the market in North America.
The market in the U.S. is anticipated to grow over the forecast period, driven by continuous innovation and the efforts of key market players. Companies like Medtronic, Philips Healthcare, and GE Healthcare are at the forefront, developing advanced pressure monitoring devices with enhanced accuracy, connectivity, and user-friendliness. Innovations such as wireless technology and integration with digital health platforms are improving patient outcomes and compliance. For instance, in April 2023, Cadence and Providence introduced a remote patient monitoring program to enhance quality and access to home-based care. Two successful clinic launches in Washington have shown strong patient engagement and medication adherence among those with congestive heart failure and hypertension. Additionally, the increasing prevalence of hypertension and other chronic conditions is fueling demand for these cutting-edge monitoring solutions.
The Europe market is anticipated to experience significant growth during the forecast period, due to the high prevalence of hypertension, affecting a significant portion of the adult population. According to a study published by ScienceDirect in December 2023, hypertension affects over 30% of the population in France. Increasing awareness about cardiovascular health and the need for regular monitoring drive demand for advanced pressure monitoring devices, enhancing early diagnosis and management of hypertension across the region.
The UK pressure monitoring market is influenced by various factorsdue to the increasing prevalence of cardiovascular disorders. In 2022, 2.3 million people in the UK were living with coronary heart disease (CHD), including around 1.5 million men and 830,000 women. Individuals with CHD or a history of heart attacks are twice as likely to experience a stroke. Rising awareness of the importance of early detection and management of conditions like hypertension drives demand for advanced pressure monitoring devices, enhancing patient outcomes and supporting overall market expansion.
The pressure monitoring market in Germany is expected to grow over the forecast period, due to significant technological advancements and innovation. Cutting-edge developments, such as wireless monitoring devices and integration with digital health platforms, enhance accuracy and ease of use. These innovations improve patient monitoring and management, driving market growth and positioning Germany as a leader in advanced healthcare solutions.
The Asia Pacific market is experiencing significant growth driven by the rising prevalence of hypertension and increasing demand for homecare solutions. The National Family Health Survey (NFHS-5) reported a hypertension prevalence of 24% in men and 21% in women for 2019-21, an increase from 19% and 17%, respectively, in the previous survey conducted in 2015-16. The growth of online healthcare platforms facilitates easy access to advanced monitoring devices, enabling patients to manage their blood pressure at home. This trend supports better disease management and contributes to market growth in the region.
The China pressure monitoring market is witnessing innovation due to substantial healthcare investments and the presence of key players. These investments are driving innovation and the development of advanced monitoring technologies. Increased focus on improving healthcare infrastructure and addressing the rising prevalence of hypertension further supports the market's expansion.
The pressure monitoring market in Japan is expected to witness a rapid growth over the forecast due to significant technological innovations. Breakthroughs in sensor technology, integration with digital health platforms, and development of noninvasive and wearable devices are enhancing the accuracy and convenience of pressure monitoring. These advancements are driving market growth by improving patient outcomes and supporting more efficient management of cardiovascular conditions.
The market in the Middle East and Africa is driven by the rising incidence of high blood pressure and cardiovascular diseases. Increased awareness and demand for effective monitoring solutions are fueling market expansion. Advances in technology and greater healthcare investment are further supporting the development and adoption of pressure monitoring devices in the region.
The pressure monitoring market in Saudi Arabia is expected to grow over the forecast perioddue to increased healthcare investments and advancements in technology. Enhanced medical infrastructure and innovations in monitoring devices are driving growth, improving the management of cardiovascular conditions and patient care in the region.
Key players operating in the market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are playing a key role in propelling the market growth.
The following are the leading companies in the pressure monitoring market. These companies collectively hold the largest market share and dictate industry trends.
In January 2024, Pylo Health unveiled the release of two advanced patient devices: the Pylo 200-LTE weight scale and Pylo 900-LTE blood pressure monitor.
In July 2024, Lindus Health and Aktiia announced the initiation of a clinical trial to assess user satisfaction with Aktiia's optical blood pressure monitoring (OBPM) device among individuals with hypertension.
In August 2023, EPIC Health, Detroit's community-centered health system, and OMRON Healthcare, announced a new partnership to tackle health disparities and lower the risk of heart attacks and strokes in underserved Detroit neighborhoods. The initiative will introduce VitalSight, OMRON's inaugural remote patient monitoring service tailored for individuals with high blood pressure, particularly those suffering from uncontrolled Stage 2 hypertension.
Report Attribute |
Details |
Market size value in 2024 |
USD 12.5 billion |
Revenue forecast in 2030 |
USD 20.3 billion |
Growth rate |
CAGR of 8.4% from 2024 to 2030 |
Actual data |
2018 - 2023 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, procedure, application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Philips Healthcare; GE Healthcare; Welch Allyn, Inc.; Medtronic; Dragerwerk; Omron Healthcare Welch Allyn, Inc.; A&D Medical Inc.; SunTech Medical, Inc.; American Diagnostics Corp.; Withings; Briggs Healthcare; Rossmax International Ltd.; Spacelabs Healthcare Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pressure monitoring market report based on product, procedure, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
BP Monitors/Cardiac Pressure Monitors
Device
Automated BP Monitors
Ambulatory BP Monitors
Sphygmomanometers
BP Transducers
Accessories
BP Cuffs
Manometers
Valves and Tubings
Bulbs
Pulmonary Pressure Monitors
Device
Oximeters
Capnographs
Spirometers
Accessories
Flanged Mouth Pieces
Nasal Probes & Plugs
Filters
Intraocular Pressure Monitors
Device
Accessories
Prisms
Tip Covers
Sensors
Intracranial Pressure Monitors
Procedure Outlook (Revenue, USD Million, 2018 - 2030)
Noninvasive
Invasive
Application Outlook (Revenue, USD Million, 2018 - 2030)
Respiratory Disorders
Glaucoma
Cardiac Disorders
Neurological Disorders
Dialysis
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Home Care Settings
Ambulatory Surgical Centers and Clinics
Diagnostic Laboratories
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
b. The global pressure monitoring market size was estimated at USD 11.6 billion in 2023 and is expected to reach USD 12.5 billion in 2024.
b. The global pressure monitoring market is expected to show a healthy growth rate in the next five years. The rising prevalence of cardiac diseases and geriatric population.
b. North America dominated the pressure monitoring market in 2023. This is attributable to the rapid adoption of sedentary lifestyles, technological advancements, and presence of key market players.
b. Some key players operating in the telemedicine market include Philips Healthcare; Welch Allyn; GE Healthcare; Drägerwerk AG & Co. KGaA; Medtronic; Becton, Dickinson and Company; Nonin Medical Inc.; A&D Medical; NIHON KOHDEN CORPORATION; Smiths Medical; Icare Finland Oy; Essilor; and NIDEK CO., LTD.
b. Key factors that are driving the market growth include increasing prevalence of high blood pressure, launch of wearable devices, and rising ageing population.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."